Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | 17-beta-hydroxysteroid dehydrogenase type 2 |
---|
Ligand | BDBM50358116 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_938953 (CHEMBL2328442) |
---|
IC50 | 50±n/a nM |
---|
Citation | Marchais-Oberwinkler, S; Xu, K; Wetzel, M; Perspicace, E; Negri, M; Meyer, A; Odermatt, A; Möller, G; Adamski, J; Hartmann, RW Structural optimization of 2,5-thiophene amides as highly potent and selective 17ß-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis. J Med Chem56:167-81 (2013) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
17-beta-hydroxysteroid dehydrogenase type 2 |
---|
Name: | 17-beta-hydroxysteroid dehydrogenase type 2 |
Synonyms: | 17-beta-Hydroxysteroid Dehydrogenase 2 (17-beta-HSD2) | 20 alpha-hydroxysteroid dehydrogenase | 20-alpha-HSD | DHB2_HUMAN | EDH17B2 | Estradiol 17-beta-dehydrogenase 2 | Estradiol 17-beta-dehydrogenase 2 (17beta-HSD2) | HSD17B2 | Microsomal 17-beta-hydroxysteroid dehydrogenas | SDR9C2 | Testosterone 17-beta-dehydrogenase |
Type: | Oxidoreductase; single-pass type II membrane protein |
Mol. Mass.: | 42795.29 |
Organism: | Homo sapiens (Human) |
Description: | Enzyme was partially purified from human placenta. |
Residue: | 387 |
Sequence: | MSTFFSDTAWICLAVPTVLCGTVFCKYKKSSGQLWSWMVCLAGLCAVCLLILSPFWGLIL
FSVSCFLMYTYLSGQELLPVDQKAVLVTGGDCGLGHALCKYLDELGFTVFAGVLNENGPG
AEELRRTCSPRLSVLQMDITKPVQIKDAYSKVAAMLQDRGLWAVINNAGVLGFPTDGELL
LMTDYKQCMAVNFFGTVEVTKTFLPLLRKSKGRLVNVSSMGGGAPMERLASYGSSKAAVT
MFSSVMRLELSKWGIKVASIQPGGFLTNIAGTSDKWEKLEKDILDHLPAEVQEDYGQDYI
LAQRNFLLLINSLASKDFSPVLRDIQHAILAKSPFAYYTPGKGAYLWICLAHYLPIGIYD
YFAKRHFGQDKPMPRALRMPNYKKKAT
|
|
|
BDBM50358116 |
---|
n/a |
---|
Name | BDBM50358116 |
Synonyms: | CHEMBL1915968 |
Type | Small organic molecule |
Emp. Form. | C21H20N2O2S |
Mol. Mass. | 364.461 |
SMILES | CN1[C@H]([C@H](O)c2ccc(s2)-c2cccnc2)[C@@H](CC1=O)c1ccccc1 |r| |
Structure |
|